Posted by Michael Wonder on 13 Sep 2016
CADTH calls for patient input on submission from Sanofi for sarilumab
13 September 2016 - CADTH is calling for patient input on Sanofi Genzyme's new interleukin 6 receptor antagonist.
Sanofi is seeking a recommendation from CADTH on the reimbursement of sarilumab for use by patients with rheumatoid arthritis.
The submission is due on 12 October 2016.
